NCT06637007View on ClinicalTrials.gov

Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Sarcoma,Soft TissueSarcomaSarcoma of Bone
Interventions
DRUG

Chidamide Tablets combined with AK112

Chidamide Tablets 30mg/day, po.Bid; AK112（10mg/kg or 20mg/kg）, ivgtt, Q3W.

Trial Locations (1)

030000

RECRUITING

Shanxi Cancer Hospital, Taiyuan

All Listed Sponsors
lead

Shanxi Province Cancer Hospital

OTHER